Schedule 13D ownership disclosure
N/A
Common Stock, par value $0.001 per share · CUSIP: 282559103
Event date: 2025-01-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.Reported CIK 0001346824
Shares: 20,013,733.00 · Class: 15.1%
- Peter KolchinskyReported CIK 0001384859
Shares: 20,013,733.00 · Class: 15.1%
- Rajeev ShahReported CIK 0001619841
Shares: 20,013,733.00 · Class: 15.1%
- RA Capital Healthcare Fund LPReported CIK 0001315082
Shares: 19,554,319.00 · Class: 14.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-002762
- Form type
- SCHEDULE 13D/A
- Filer
- 89bio, Inc.
- CIK
- CIK 1785173
- Filed
- Feb 03, 2025
- Reporting period
- Jan 30, 2025
- Description
- Schedule 13D beneficial ownership